SHANGHAI FOSUN PHARMACEUTICAL GROUPSHANGHAI FOSUN PHARMACEUTICAL GROUPSHANGHAI FOSUN PHARMACEUTICAL GROUP

SHANGHAI FOSUN PHARMACEUTICAL GROUP

No trades
See on Supercharts

2196 fundamentals

SHANGHAI FOSUN PHARMACEUTICAL GROUP key financial stats and ratios

2196 price-to-sales ratio is 0.90. The company has an Enterprise Value to EBITDA ratio of 21.51. As of 2023 they employed 40.37 k people.

Statistics
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: HKD
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios